Webb-500×300

Swedish Life Science Investor Meeting – brings together Swedish life science companies and investors

Swedish Life Science Investor Meeting – brings together Swedish life science companies and investors

The event offers 1:1 meetings between Swedish life science companies and investors. This match-making event brings together Swedish life science companies from all growth phases and investors. The ambition is to offer an arena for Swedish life science companies to establish new investor relations and to find investment opportunities.

This is a “book-and-meet” event without a conference program. As a participant you can easily screen, book and take one-to-one video-meetings – we all meet online from wherever you are.

For who?

  • Swedish life science companies
    • Companies reached TRL 4 and beyond (more info under Readiness levels)
    • Companies not listed on the stock exchange 
  • Investors
    • Complimentary registration for qualified investors defined as institutional, private equity, venture investors, business angels, family offices, corporate ventures and independent investors.
    • Your registration in this category is submitted for validation. Please note that consulting firms, investment advisors and other services related companies are not eligible to complimentary registration.

This event will offer:

Your participation involves multiple slots between November 17 – 18, 2021.

  • 2 days of one-to-one meetings with investors, pharmaceutical-, diagnostic-, medtech- and biotech companies
  • Online booking of video-meetings

Cost

Startups participate at fee of 2 500SEK, VAT included.

Important deadlines


  • June: Registration opens
  • October 12 – November 18: Scheduling of one-to-one meetings
  • November 17 – 18: Pre-booked one-to-one video-meetings

Read more and sign up until 18 November here

For questions, contact 

Sofia Hjelmberg, GU Ventures

AKTUELLT


NYHETSBREV


Följ nyheter och utlysningar från Medtech4Health – prenumera på vårt nyhetsbrev.

Dela gärna detta!

Publicerad: 22 oktober 2021

AKTUELLT


NYHETSBREV


Följ nyheter och utlysningar från Medtech4Health - prenumera på vårt nyhetsbrev.